HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

pegfilgrastim (Neulasta)

pegylated (r-G-CSF) conjugated to polyethylene glycol for treatment of neutropenic patients with non-myeloid malignancies who are at high risk for infection
Also Known As:
Neulasta; Amgen brand of pegfilgrastim; PEG SD-01; PEG-rmetHuG-CSF; SD-01, polyethylene glycol-conjugated filgrastim; SD-01-filgrastim
Networked: 303 relevant articles (58 outcomes, 100 trials/studies)

Relationship Network

Drug Context: Research Results

Experts

1. Lyman, Gary H: 9 articles (06/2014 - 07/2004)
2. Crawford, Jeffrey: 8 articles (10/2013 - 01/2002)
3. Malin, Jennifer: 7 articles (06/2012 - 05/2007)
4. Bias, Peter: 6 articles (01/2016 - 01/2013)
5. Yang, Bing-Bing: 6 articles (06/2015 - 10/2007)
6. Dreiling, Lyndah: 6 articles (05/2010 - 04/2007)
7. Buchner, Anton: 5 articles (01/2016 - 01/2013)
8. Barron, Richard: 5 articles (11/2015 - 02/2009)
9. Balducci, Lodovico: 5 articles (12/2014 - 10/2003)
10. Danova, Marco: 5 articles (09/2014 - 09/2007)

Related Diseases

1. Neutropenia
2. Breast Neoplasms (Breast Cancer)
3. Lymphoma (Lymphomas)
4. Neoplasms (Cancer)
5. Infection

Related Drugs and Biologics

1. Filgrastim (Neupogen)
2. Granulocyte Colony-Stimulating Factor (G-CSF)
3. docetaxel (Taxotere)
4. Doxorubicin (Adriamycin)
5. darbepoetin alfa (Aranesp)
6. lenograstim
7. Epirubicin (Ellence)
8. pegfilgrastim (Neulasta)
9. Paclitaxel (Taxol)
10. Topotecan (Hycamtin)

Related Therapies and Procedures

1. Drug Therapy (Chemotherapy)
2. Injections
3. Transplantation (Transplant Recipients)
4. Subcutaneous Injections
5. Peripheral Blood Stem Cell Transplantation (Peripheral Stem Cell Transplantation)